Results · Apr-Jun 2026 · filed 14 Aug 2026
Auro Laboratories Q1 FY27 results
Sales grew 216% to ₹8.8 crore from ₹2.8 crore in Apr-Jun 2025.
Operating profit grew 9943% to ₹3.3 crore, an operating margin of 37.7% (up 36.5 points from a year ago).
Net profit turned positive: ₹1 crore against a loss of ₹0.11 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −11%, net profit +8%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 8.8 | 2.8 | +216% |
| Operating profit (EBITDA) | 3.3 | 0.0 | +9943% |
| Operating margin | 37.7% | 1.2% | +36.5 pts |
| Net profit | 1.0 | -0.1 | turns positive |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 17 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 14 Aug 2026 Un-Audited Financial Results For The Quarter Ended June 30, 2026.
- 14 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2026.
- 13 Aug 2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 11 Aug 2026Shareholder Meeting / Postal Ballot-Outcome of AGM
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.